## Abstract Renal cell carcinoma (RCC) is one of the most drug‐resistant malignancies in humans. We show that adriamycin (ADR) and TNF‐related apoptosis‐inducing ligand (TRAIL)/Apo2L have a synergistic cytotoxic effect against RCC cells. This synergistic cytotoxicity was obtained in ACHN, A704, Cak
Depression of monocyte-mediated cytotoxicity by renal carcinoma and restoration through therapy
✍ Scribed by Geirmund Unsgaard; Bjørn Magne Eggen; Jon Lamvik
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 405 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
✦ Synopsis
The cytotoxic ability of freshly isolated monocytes against the tumor cell line K-562 was severely depressed in patients with renal cell carcinoma.
The impaired cytotoxicity was partly restored 2 weeks after nephrectomy .
Production of monocyte-activating lymphokine, measured as ability to activate tumor cytotoxicity in control monocytes, was depressed in lymphocytes from patients with tumor burden. The impaired lymphokine production seemed to be due to factors in patient serum. Patient monocytes showed an impaired ability to be activated by lymphokines. Products from patient lymphocytes were not able to activate the tumor cytotoxicity of patient monocytes.
📜 SIMILAR VOLUMES